ZNF548
Zinc finger protein 548
Also known as: FLJ32932, ZN548_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NEK5
- Gene
- ZNF548
- Ensembl
- ENSG00000188785
- Chromosome
- 19
- Canonical length
- 533 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
533 residues, UniProt reviewed canonical sequence.
>Q8NEK5|ZNF548
1 MNLTEGRVVF EDVAIYFSQE EWGHLDEAQR LLYRDVMLEN LALLSSLGSW HGAEDEEAPS
61 QQGFSVGVSE VTASKPCLSS QKVHPSETCG PPLKDILCLV EHNGIHPEQH IYICEAELFQ
121 HPKQQIGENL SRGDDWIPSF GKNHRVHMAE EIFTCMEGWK DLPATSCLLQ HQGPQSEWKP
181 YRDTEDREAF QTGQNDYKCS ECGKTFTCSY SFVEHQKIHT GERSYECNKC GKFFKYSANF
241 MKHQTVHTSE RTYECRECGK SFMYNYRLMR HKRVHTGERP YECNTCGKFF RYSSTFVRHQ
301 RVHTGERPYE CRECGKFFMD SSTLIKHQRV HTGERPYKCN DCGKFFRYIS TLIRHQRIHT
361 GERPYECSVC GELFRYNSSL VKHWRNHTGE RPYKCSECGK SFRYHCRLIR HQRVHTGERP
421 YECSECGKFF RYNSNLIKHW RNHTGERPYE CRECGKAFSH KHILVEHQKI HSGERPYECS
481 ECQKAFIRKS HLVHHQKIHS EERLVCSMNV GNSLAKTPTS LNIRDFTMEK VYHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF548 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 25 nTPM
- lymph node: 22 nTPM
- spleen: 18 nTPM
- tonsil: 17 nTPM
- appendix: 16 nTPM
- thymus: 12 nTPM
Single-cell type
- gastric chief cells: 1.1 nCPM
- breast myoepithelial cells: 0.9 nCPM
- basal prostatic cells: 0.6 nCPM
- epididymal basal cells: 0.5 nCPM
- hematopoietic stem cells: 0.5 nCPM
- innate lymphoid cells: 0.5 nCPM
Immune cell
- naive B-cell: 8.4 nTPM
- T-reg: 7 nTPM
- naive CD8 T-cell: 5.8 nTPM
- MAIT T-cell: 5.6 nTPM
- naive CD4 T-cell: 5.5 nTPM
- memory CD8 T-cell: 5.2 nTPM
Brain region
- cerebellum: 36 nTPM
- cerebral cortex: 35 nTPM
- white matter: 27 nTPM
- hippocampal formation: 27 nTPM
- choroid plexus: 26 nTPM
- hypothalamus: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF548 as an antibody target. Whether an autoantibody or antibody against ZNF548 could matter depends on whether native ZNF548 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF548 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF548 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...